Marketzone with MT Newswires 2022 All the news about MADRIGAL PHARMACEUTICALS, INC. |
| | |
Analyst Recommendations for MADRIGAL PHARMACEUTICALS, INC. |
| | |
|
|
2022 turnover |
–
–
– | 2022 net result |
-274M
–
-270M | trso. net 2022 |
84.7M
–
83.4M | PER 2022 | -5.16x | 2022 return | – |
| Capitalization |
1,229M
1,229M
1,210M | VE / CA 2022 | – | VE / CA 2023 | 28.6x | Number of employees | 71 | Floating | 79.6% |
|
Chart MADRIGAL PHARMACEUTICALS, INC. |
|
Hard :
Period:
|
| |
Trends Technical Analysis MADRIGAL PHARMACEUTICALS, INC.
| Short term | Middle term | Long term | Trends | Neutral | Neutral | Neutral | Evolution of the Income Statement | Average recommendation | TO BUY | Number of Analysts | 13 | Last Closing Price | $79.51 | Average price target | $157.17 | Deviation / Average Target | 97.7% |
|
Source link -88